The Impact of Storage Techniques on Platelets Number and Function After Acute Normovolemic Hemodilution (ANH)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02060838 |
|
Recruitment Status :
Completed
First Posted : February 12, 2014
Results First Posted : March 31, 2017
Last Update Posted : March 31, 2017
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Cardiac Surgical Procedures | Procedure: Acute normovolemic hemodilution (ANH) |
| Study Type : | Observational |
| Actual Enrollment : | 50 participants |
| Observational Model: | Case-Only |
| Time Perspective: | Prospective |
| Study Start Date : | March 2014 |
| Actual Primary Completion Date : | September 2016 |
| Actual Study Completion Date : | September 2016 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Acute normovolemic hemodilution (ANH)
Patients undergoing acute normovolemic hemodilution (ANH) as part of their cardiac surgery.
|
Procedure: Acute normovolemic hemodilution (ANH)
Blood is drawn from our patients pre-bypass after obtaining the arterial line and administered back to the patient after separation from cardiopulmonary bypass (CPB) and reversal of heparin with protamine. |
- Time to Platelet Aggregation as Measured Using Collagen-epinephrine (EPI) [ Time Frame: Just prior to re-transfusion, assessed up to 5 minutes ]The membrane of the cartridges are coated with collagen and epinephrine (EPI) inducing a platelet plug to form which closes the aperture.
- Time to Platelet Aggregation as Measured Using Collagen-Adenosine (ADP) [ Time Frame: Just prior to re-transfusion, assessed up to 5 minutes ]The membrane of the cartridges are coated with collagen and adenosine diphosphate (ADP) inducing a platelet plug to form which closes the aperture.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All patients undergoing cardiac surgery on CPB and are determined to be suitable for ANH by the cardiac team during the huddle process per our standard protocol.
Exclusion Criteria:
- Patients who are undergoing cardiac surgery on CPB who are determined not to be suitable candidates for ANH by the cardiac team during the huddle process per our standard protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02060838
| United States, Ohio | |
| Nationwide Children's Hospital | |
| Columbus, Ohio, United States, 43205 | |
| Responsible Party: | Aymen N Naguib, Director of Pediatric Cardiothoracic Anesthesia, Nationwide Children's Hospital |
| ClinicalTrials.gov Identifier: | NCT02060838 |
| Other Study ID Numbers: |
IRB13-00762 |
| First Posted: | February 12, 2014 Key Record Dates |
| Results First Posted: | March 31, 2017 |
| Last Update Posted: | March 31, 2017 |
| Last Verified: | October 2016 |

